These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 20797774)
1. Short versus extended thromboprophylaxis after total knee arthroplasty: a randomized comparison. Barrellier MT; Lebel B; Parienti JJ; Mismetti P; Dutheil JJ; Vielpeau C; ; Thromb Res; 2010 Oct; 126(4):e298-304. PubMed ID: 20797774 [TBL] [Abstract][Full Text] [Related]
2. [Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery]. Barrellier MT; Samama CM J Mal Vasc; 2013 May; 38(3):178-84. PubMed ID: 23415379 [TBL] [Abstract][Full Text] [Related]
3. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497 [TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG; N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812 [TBL] [Abstract][Full Text] [Related]
5. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942 [TBL] [Abstract][Full Text] [Related]
6. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial). Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J; Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513 [TBL] [Abstract][Full Text] [Related]
8. Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopedic surgery. Schellong S; Hesselschwerdt HJ; Paar WD; von Hanstein KL Thromb Haemost; 2005 Sep; 94(3):532-6. PubMed ID: 16268468 [TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W; N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811 [TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465 [TBL] [Abstract][Full Text] [Related]
11. Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population. Fong YK; Ruban P; Yeo SJ; Lee BP; Lo NN; Seow KH; Ng SC Ann Acad Med Singap; 2000 Jul; 29(4):439-41. PubMed ID: 11056771 [TBL] [Abstract][Full Text] [Related]
12. [Deep venous thrombosis (DVT) after hip or knee prosthesis. Evaluation of practices for prevention and prevalence of DVT on doppler ultrasonography]. Villemur B; Bosson JL; Diamand JM J Mal Vasc; 1998 Oct; 23(4):257-62. PubMed ID: 9827404 [TBL] [Abstract][Full Text] [Related]
13. Total knee replacement: prevention of deep-vein thrombosis using pharmacological (low-molecular-weight heparin) and mechanical (intermittent foot sole pump system) combined prophylaxis. Preliminary results. Giannoni MF; Ciatti R; Capoccia L; Ruggiero M; Dauri M; Mariani PP Int Angiol; 2006 Sep; 25(3):316-21. PubMed ID: 16878083 [TBL] [Abstract][Full Text] [Related]
14. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. Colwell CW; Berkowitz SD; Lieberman JR; Comp PC; Ginsberg JS; Paiement G; McElhattan J; Roth AW; Francis CW; J Bone Joint Surg Am; 2005 Oct; 87(10):2169-77. PubMed ID: 16203879 [TBL] [Abstract][Full Text] [Related]
16. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study. Sudo A; Sano T; Horikawa K; Yamakawa T; Shi D; Uchida A J Orthop Surg (Hong Kong); 2003 Dec; 11(2):174-7. PubMed ID: 14676343 [TBL] [Abstract][Full Text] [Related]
17. Relationship between deep vein thrombosis and pulmonary embolism following THA and TKA. Bosque J; Coleman SI; Di Cesare P Orthopedics; 2012 Mar; 35(3):228-33; quiz 234-5. PubMed ID: 22385601 [TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Robinson KS; Anderson DR; Gross M; Petrie D; Leighton R; Stanish W; Alexander D; Mitchell M; Flemming B; Gent M Ann Intern Med; 1997 Sep; 127(6):439-45. PubMed ID: 9313000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]